Answer
The selected UK product is licensed for adults. Its safety and effectiveness have not been established for people under 18.
Sources for this answer
- Cinqaero (reslizumab) 10 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.